February 2019 Vol 5 No 1
By Dawn Newton
Dawn Newton, a non-smoker diagnosed with lung cancer, chronicles her emotions as she spends time at the reception area before routine testing and while awaiting the results, knowing that at some point her cancer will stop responding to treatment. Read More ›
By Dana Taylor
Triple-negative breast cancer has few treatment options. Promising results from recent clinical trials of immunotherapy combined with chemotherapy in patients with metastatic disease may soon change the way this aggressive cancer is treated. Just after this article was written, the FDA approved this combination for patients with triple-negative breast cancer. Read More ›
By Jack Elliott
Several new treatment options were approved by the FDA for patients with follicular lymphoma. Read More ›
By Ron Baylor
A new legislation proposed by the Trump administration aims at lowering the price of prescription drugs, especially the high cost of cancer drugs, for patients. Read More ›
Two integrative medicine experts explain the benefits of yoga practice for patients with cancer and their caregivers. Read More ›